Adstiladrin 3×1011 viral particles (vp)/mL suspension for intravesical use Images
Generic Name: nadofaragene firadenovec
This medication has been identified as Adstiladrin 3×1011 viral particles (vp)/mL suspension for intravesical use. It is supplied by Ferring Pharmaceuticals Inc.
Adstiladrin is used in the treatment of Bladder Cancer and belongs to the drug class miscellaneous antineoplastics. Adstiladrin 3×1011 viral particles (vp)/mL suspension for intravesical use is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Adstiladrin
- Generic Name
- nadofaragene firadenovec
- Strength
- 3×1011 viral particles (vp)/mL suspension for intravesical use
- Availability
- Prescription only
- Drug Class
- Miscellaneous antineoplastics
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ferring Pharmaceuticals Inc.
- National Drug Code (NDC)
- 55566-1050
More about Adstiladrin (nadofaragene firadenovec)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.